2021 ICD-10-CM Code D03.7

Melanoma in situ of lower limb, including hip

Version 2021

Not Valid for Submission

D03.7 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of melanoma in situ of lower limb, including hip. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

ICD-10:D03.7
Short Description:Melanoma in situ of lower limb, including hip
Long Description:Melanoma in situ of lower limb, including hip

Code Classification

Specific Coding for Melanoma in situ of lower limb, including hip

Non-specific codes like D03.7 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for melanoma in situ of lower limb, including hip:

  • BILLABLE CODE - Use D03.70 for Melanoma in situ of unspecified lower limb, including hip
  • BILLABLE CODE - Use D03.71 for Melanoma in situ of right lower limb, including hip
  • BILLABLE CODE - Use D03.72 for Melanoma in situ of left lower limb, including hip

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D03.7 are found in the index:

Information for Patients


Melanoma

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."

Thinking of "ABCDE" can help you remember what to watch for:

Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)